India
SC says pharma firms cannot 'run amok' on medicine prices
The Supreme Court said the pharmaceutical industry cannot be allowed to run amok in the name of the free market by fixing medicine MRPs, in some cases over 1,000% above the price charged to retailers. A bench of Justices Vikram Nath and Sandeep Mehta said it was pained by the loot and reserved its order on a plea seeking price control for all non-patented medicines.
This summary is based on reporting by The Times of India.
Read the full story at The Times of IndiaAdvertisement